Successful extension of tocilizumab infusion intervals from 4 weeks to 5 or 6 weeks in 90% of rheumatoid arthritis patients with good response to 4-week intervals

Saiki O.; Uda H.

首页> 外文期刊>Clinical and experimental rheumatology >Successful extension of tocilizumab infusion intervals from 4 weeks to 5 or 6 weeks in 90% of rheumatoid arthritis patients with good response to 4-week intervals

【24h】

Successful extension of tocilizumab infusion intervals from 4 weeks to 5 or 6 weeks in 90% of rheumatoid arthritis patients with good response to 4-week intervals

机译：在90％的类风湿性关节炎患者中成功地将与过硅胶输注间隔从4周到5或6周的延长患者，患者的患者良好地回应4周的间隔

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective

机译：客观的

著录项

来源
《Clinical and experimental rheumatology》 |2017年第4期|共5页
作者
Saiki O.; Uda H.;
展开▼
作者单位

Higashiosaka City Gen Hosp Dept Rheumatol 3-4-5 Nisiiwata Higashiosaka Osaka 5788588 Japan;

Higashiosaka City Gen Hosp Dept Rheumatol 3-4-5 Nisiiwata Higashiosaka Osaka 5788588 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
rheumatoid arthritis; tocilizumab; extension of intervals;

机译：类风湿性关节炎;TOCOLIZUMAB;延伸间隔;

相似文献

外文文献
中文文献
专利

1. Successful extension of tocilizumab infusion intervals from 4 weeks to 5 or 6 weeks in 90% of rheumatoid arthritis patients with good response to 4-week intervals [J] . Saiki O., Uda H. Clinical and experimental rheumatology . 2017,第4期

机译：在90％的类风湿性关节炎患者中成功地将与过硅胶输注间隔从4周到5或6周的延长患者，患者的患者良好地回应4周的间隔
2. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period [J] . Ogata Atsushi, Tanaka Yoshiya, Ishii Tomonori, Modern rheumatology . 2018,第1期

机译：随机，双盲，并行组，第三阶段研究缩短皮下对毒素关节炎患者的皮下对照单药治疗和对皮下对照的反应不充分的每隔一周：12周双盲时期的结果
3. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period (vol 28, pg 76, 2017) [J] . Ogata Atsushi, Tanaka Yoshiya, Ishii Tomonori, Modern rheumatology . 2018,第1期

机译：随机，双盲，并行组，第三阶段研究，缩短皮下对类风湿性关节炎患者的皮下硅酸化单疗法的剂量间隔，以及对皮下对皮下丁证的反应不足：12周双盲期的结果（ Vol 28，PG 76,2017）
4. Human Antichimeric Antibodies to Infliximab and Infusion-Related Allergic Reactions in Patients with Rheumatoid Arthritis [C] . D. Wouters, S. Stapel, M. Vis, Collegium Internationale Allergologicum . 2007

机译：人的苯甲酸纤维化率和类风湿性关节炎患者的infumency相关过敏反应的抗体抗体
5. Influence of rest interval length in between sets on hormonal responses and changes in body composition, muscular strength, and functional performance during twelve weeks of periodized resistance training in older men. [D] . Villanueva, Matthew Gaston. 2013

机译：组之间的休息间隔时间长度对荷尔蒙反应以及年龄较大的男性进行定期抵抗训练十二周期间的身体成分，肌肉力量和功能表现的变化的影响。
6. Extended report: Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective randomised controlled study (SURPRISE study) [O] . Yuko Kaneko, Tatsuya Atsumi, Yoshiya Tanaka, -1

机译：扩展报告：类风湿关节炎对甲氨蝶呤反应不佳的患者中在甲氨蝶呤中添加托珠单抗与切换至托珠单抗的比较：一项前瞻性随机对照研究（SURPRISE研究）的52周结果
7. A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period [O] . Atsushi Ogata, Yoshiya Tanaka, Tomonori Ishii, 2017

机译：随机，双盲，并行组，第三阶段研究缩短了类风湿性关节炎患者的皮下对硅酸化单药治疗的剂量间隔及对皮下丁证的反应不足：12周双盲期的结果

Successful extension of tocilizumab infusion intervals from 4 weeks to 5 or 6 weeks in 90% of rheumatoid arthritis patients with good response to 4-week intervals

摘要

著录项

相似文献

相关主题

期刊订阅